Disclosure Of Interests In Other Entities [Text Block]

Zealand Pharma - Filing #1417063

Concept 2021-01-01 to
2021-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
As at
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2019-01-01 to
2019-12-31
2019-01-01 to
2019-12-31
As at
2019-12-31
2019-01-01 to
2019-12-31
2019-01-01 to
2019-12-31
2019-01-01 to
2019-12-31
2019-01-01 to
2019-12-31
As at
2018-12-31
Disclosure of interests in other entities [text block]
Disclosure of interests in subsidiaries [text block]
Disclosure of subsidiaries [text block]
Disclosure of subsidiaries [abstract]
Disclosure of subsidiaries [line items]
Current assets
1,721,596,000 DKK
1,419,688,000 DKK
Non-current assets
346,033,000 DKK
342,261,000 DKK
Current liabilities
334,317,000 DKK
355,260,000 DKK
Non-current liabilities
805,509,000 DKK
177,378,000 DKK
Revenue
292,567,000 DKK
353,314,000 DKK
41,333,000 DKK
Profit (loss)
0 DKK
0 DKK
0 DKK
0 DKK
1,018,149,000 DKK
1,018,149,000 DKK
846,729,000 DKK
0 DKK
846,729,000 DKK
0 DKK
0 DKK
0 DKK
0 DKK
571,541,000 DKK
571,541,000 DKK
0 DKK
0 DKK
0 DKK
Comprehensive income
1,012,972,000 DKK
837,752,000 DKK
571,541,000 DKK
Disclosure of interests in associates [text block]
Disclosure of associates [text block]
Disclosure of associates [abstract]
Disclosure of associates [line items]
Other comprehensive income
0 DKK
0 DKK
5,178,000 DKK
0 DKK
5,178,000 DKK
0 DKK
8,977,000 DKK
0 DKK
0 DKK
0 DKK
8,977,000 DKK
0 DKK
0 DKK
0 DKK
0 DKK
0 DKK
0 DKK
0 DKK
Disclosure of interests in joint arrangements [text block]
Disclosure of joint ventures [text block]
Disclosure of joint ventures [abstract]
Disclosure of joint ventures [line items]
Cash and cash equivalents
1,129,103,000 DKK
960,221,000 DKK
1,081,060,000 DKK
860,635,000 DKK
Tax expense (income)
8,791,000 DKK
7,076,000 DKK
5,136,000 DKK

Talk to a Data Expert

Have a question? We'll get back to you promptly.